⌘K
Loading ticker…
As of 2026-08-24, Avient Corporation (AVNT) has a 3-month relative strength percentile of 87 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 59. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 3.3%, relative volume 0.88×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
AVNT is in a stage 2 uptrend, week 3. Currently in a 6-day base; basing ADR 2.5% (broad 3.3%). VCP detected: no. RS line below base-start high. Distance from 50d / 200d: 13.8% / 23.5%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
AVNT is held by 37 ETFs as of May 2026. Top owner: REGL at 1.46% weight, $25M notional. Top 3 carry $57M.
Held by 110 ETFs · $813M across latest filings · largest weight 2.49% (SCAP).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| REGL | 1.46% | $25M | −0.16 pp |
| VTWO | 0.10% | $17M | −0.03 pp |
| SCHASchwab U.S. Small-Cap ETF | 0.07% | $16M | −0.02 pp |
| FNDA | 0.17% | $15M | −0.03 pp |
| VAWVanguard Materials ETF | 0.21% | $9M | −0.02 pp |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| SMDV |
| 0.92% |
| $6M |
| −0.29 pp |
| IVOO | 0.09% | $5M | −0.02 pp |
| AVSC | 0.15% | $4M | +0.06 pp |
| MSSM | 0.39% | $3M | −0.06 pp |
| IVOV | 0.19% | $3M | −0.03 pp |
Showing 10 of 37 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AVNT Jan avg: 6.96% median: 10.36% win: 75% σ: 14.67% n: 4 2022-04-12 → 2026-07-31 | AVNT Feb avg: 8.19% median: 9.73% win: 75% σ: 6.19% n: 4 2022-04-12 → 2026-07-31 | AVNT Mar avg: -5.79% median: -8.64% win: 25% σ: 9.25% n: 4 2022-04-12 → 2026-07-31 | AVNT Apr avg: -1.97% median: -2.26% win: 40% σ: 6.87% n: 5 2022-04-12 → 2026-07-31 | AVNT May avg: 0.80% median: -0.08% win: 40% σ: 6.00% n: 5 2022-04-12 → 2026-07-31 | AVNT Jun avg: -3.00% median: -2.31% win: 40% σ: 12.04% n: 5 2022-04-12 → 2026-07-31 | AVNT Jul avg: 1.27% median: -0.91% win: 40% σ: 4.27% n: 5 2022-04-12 → 2026-07-31 | AVNT Aug avg: 6.90% median: 5.09% win: 75% σ: 8.72% n: 4 2022-04-12 → 2026-07-31 (current) | AVNT Sep avg: -13.07% median: -11.92% win: 25% σ: 13.66% n: 4 2022-04-12 → 2026-07-31 | AVNT Oct avg: -1.67% median: -5.02% win: 25% σ: 10.82% n: 4 2022-04-12 → 2026-07-31 | AVNT Nov avg: 3.58% median: 4.49% win: 75% σ: 6.92% n: 4 2022-04-12 → 2026-07-31 | AVNT Dec avg: 0.10% median: -0.17% win: 50% σ: 16.96% n: 4 2022-04-12 → 2026-07-31 |